Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance, beginning of period (in Shares) at Dec. 31, 2019   25,371,186    
Balance, beginning of period at Dec. 31, 2019   $ 3 $ 66,503 $ (49,930)
Issuance of common stock   3,634,123    
Issuance of common stock, value   $ 0    
Fair value of Private Warrants converted to Public Warrants     0  
Stock-based compensation     147  
Stock issued under stock compensation plan     0  
Share proceeds receivable     91  
Debt discount beneficial conversion feature     93  
Stock issued, net of capital issuance costs     24,916  
Net loss $ (1,681)     (1,681)
Balance, end of period (in Shares) at Mar. 31, 2020   29,005,309    
Balance, end of period at Mar. 31, 2020 40,142 $ 3 91,750 (51,611)
Balance, beginning of period (in Shares) at Dec. 31, 2020   84,535,640    
Balance, beginning of period at Dec. 31, 2020 $ 356,044 $ 8 414,819 (58,783)
Issuance of common stock 3,093,984 803,505    
Issuance of common stock, value   $ 1    
Fair value of Private Warrants converted to Public Warrants     13,922  
Stock-based compensation     6,665  
Stock issued under stock compensation plan     1,191  
Share proceeds receivable     0  
Debt discount beneficial conversion feature     0  
Stock issued, net of capital issuance costs     (815)  
Net loss $ (94,734)     (94,734)
Balance, end of period (in Shares) at Mar. 31, 2021   85,339,145    
Balance, end of period at Mar. 31, 2021 $ 282,274 $ 9 $ 435,782 $ (153,517)